Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects

  • Hai‐Xia Liu
    Huadong Hospital Affiliated to Fudan University, No. 221, West Yan An Road Shanghai 200040 China
  • Li‐Li Tao
    UT Southwestern Medical Center, 6000 Harry Hines Blvd Dallas TX
  • Jing Zhang
    Zhongshan Hospital Affiliated to Fudan University, No. 180, Feng Lin Road Shanghai 200032 China
  • Ying‐Gang Zhu
    Huadong Hospital Affiliated to Fudan University, No. 221, West Yan An Road Shanghai 200040 China
  • Yu Zheng
    Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, No. 2000, Jiangyue Road Shanghai 200112 China
  • Dong Liu
    Huadong Hospital Affiliated to Fudan University, No. 221, West Yan An Road Shanghai 200040 China
  • Min Zhou
    Rui Jin Hospital, School of Medicine, Shanghai Jiaotong University, No. 197, Rui Jin Er Road Shanghai 200025 China
  • Hui Ke
    Shanghai Pulmonary Hospital Affiliated to Tongji University, No. 507, Yangpu District, Zheng Min Road Shanghai 200433 China
  • Meng‐Meng Shi
    Rui Jin Hospital, School of Medicine, Shanghai Jiaotong University, No. 197, Rui Jin Er Road Shanghai 200025 China
  • Jie‐Ming Qu
    Huadong Hospital Affiliated to Fudan University, No. 221, West Yan An Road Shanghai 200040 China

説明

<jats:p>The functional role of respiratory microbiota has attracted an accumulating attention recently. However, the role of respiratory microbiome in lung carcinogenesis is mostly unknown. Our study aimed to characterize and compare bilateral lower airway microbiome of lung cancer patients with unilateral lobar masses and control subjects. Protected bronchial specimen brushing samples were collected from 24 lung cancer patients with unilateral lobar masses (paired samples from cancerous site and the contralateral noncancerous site) and 18 healthy controls undergoing bronchoscopies and further analyzed by 16S rRNA amplicon sequencing. As results, significant decreases in microbial diversity were observed in patients with lung cancer in comparison to the controls, alpha diversity steadily declined from healthy site to noncancerous to cancerous site. Genus <jats:italic>Streptococcus</jats:italic> was significantly more abundant in cancer cases than the controls, while <jats:italic>Staphylococcus</jats:italic> was more abundant in the controls. The area under the curve of <jats:italic>genus Streptococcus</jats:italic> used to predict lung cancer was 0.693 (sensitivity = 87.5%, specificity = 55.6%). The abundance of genus <jats:italic>Streptococcus</jats:italic> and <jats:italic>Neisseria</jats:italic> displayed an increasing trend whereas <jats:italic>Staphylococcus</jats:italic> and <jats:italic>Dialister</jats:italic> gradually declined from healthy to noncancerous to cancerous site. Collectively, lung cancer‐associated microbiota profile is distinct from that found in healthy controls, and the altered cancer‐associated microbiota is not restricted to tumor tissue. The genus <jats:italic>Streptococcus</jats:italic> was abundant in lung cancer patients and exhibited moderate classification potential. The gradual microbiota profile shift from healthy site to noncancerous to paired cancerous site suggested a change of the microenvironment associated with the development of lung cancer.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ